Key statistics
52-week range
Open | 1,845.20 |
---|---|
High | 1,856.00 |
Low | 1,835.00 |
Bid | 1,846.05 |
Offer | 1,848.00 |
Previous close | 1,833.35 |
Average volume | 1.54m |
---|---|
Shares outstanding | 2.40bn |
Free float | 1.06bn |
P/E (TTM) | 42.38 |
Market cap | 4.41tn INR |
EPS (TTM) | 43.32 INR |
Annual div (ADY) | 13.50 INR |
---|---|
Annual div yield (ADY) | 0.74% |
Div ex-date | Jul 12 2024 |
Div pay-date | Aug 16 2024 |
Data delayed at least 15 minutes, as of Sep 19 2024 11:21 BST.
More ▼
- U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
- U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
- Sun Pharma Completes Taro Merger
- Sun Pharma's GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions